title: Improving the "quality of remission induction" therapy: a necessary step for increasing the cure rate in acute myelogenous leukemia.
authors.forename: Z A
authors.initials: ZA
authors.lastname: Arlin
authors.forename: E
authors.initials: E
authors.lastname: Feldman
authors.forename: L
authors.initials: L
authors.lastname: Finger
authors.forename: J
authors.initials: J
authors.lastname: Decter
authors.forename: P
authors.initials: P
authors.lastname: Cook
authors.forename: T
authors.initials: T
authors.lastname: Ahmed
authors.forename: C
authors.initials: C
authors.lastname: Puccio
authors.forename: H
authors.initials: H
authors.lastname: Chun
authors.forename: A
authors.initials: A
authors.lastname: Mittelman
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012074:Remission Induction
chemical_list: D003561:Cytarabine